Get the Stockscreener App
1.6199
6.10%
-0.1001
Catheter Precision Inc. stock is traded at $1.6199, with a volume of 1.01M.
It is down -6.10% in the last 24 hours and down -15.00% over the past month.
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
See More
Previous Close:
$1.72
Open:
$1.75
24h Volume:
1.01M
Relative Volume:
1.02
Market Cap:
$2.80M
Revenue:
$730.00K
Net Income/Loss:
$-17.48M
P/E Ratio:
-0.0464
EPS:
-34.9439
Net Cash Flow:
$-9.72M
1W Performance:
+11.38%
1M Performance:
-15.00%
6M Performance:
-35.40%
1Y Performance:
-77.72%
1-Day Range:
$1.48
$1.75
1-Week Range:
$1.36
$2.2499
52-Week Range:
$1.14
$15.68
Catheter Precision Inc. Stock (VTAK) Company Profile
Name
Catheter Precision Inc.
Sector
Industry
Phone
973 691 2000
Address
1670 Highway 160 West, Suite 205, Fort Mill
Compare VTAK vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTAK
Catheter Precision Inc.
|
1.6102 | 2.99M | 730.00K | -17.48M | -9.72M | -34.94 |
|
ABT
Abbott Laboratories
|
110.17 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
343.04 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.94 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.88 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.60 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-02-18 | Initiated | Maxim Group | Buy |
Catheter Precision Inc. Stock (VTAK) Latest News
Catheter Precision (VTAK) Secures Funding for Growth and Expansi - GuruFocus
Private flights push: $88M fuels Flyte's bid for regional air mobility - Stock Titan
Catheter Precision completes acquisition of remaining interest in Fly Flyte - TipRanks
Creatd sells remaining 80% of Fly Flyte to Catheter Precision - TipRanks
VTAK Acquires Remaining Stake in Fly Flyte from Creatd for $12M - GuruFocus
Catheter Precision, Inc. Announces Private Placement Financing and Entry into Material Definitive Agreement - Minichart
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
This Nano-Cap Medical Device Stock Soared 50% Today – What’s The Aviation Connection? - Asianet Newsable
Catheter Precision Secures $36.5M for Strategic Growth - StocksToTrade
Catheter Precision (VTAK) Completes Full Acquisition of Flyte - GuruFocus
Catheter Precision Boosts Growth with Major Financing Round - timothysykes.com
Catheter Precision (VTAK) Stock Rockets 60% Following Aviation Acquisition Announcement - MoneyCheck
Catheter Precision (VTAK) Stock Rockets 60% Following Fly Flyte Acquisition Agreement - Blockonomi
Catheter Precision (VTAK) Stock Surges 60% on Fly Flyte Aviation Deal - CoinCentral
Signing Day Sports, Inc. officially disclosed the expected completion time for its business merger plan with the blockchain digital infrastructure project. - Bitget
CREATD INC. has sold its remaining 80% stake in Fly Flyte to Catheter Precision Inc., a company listed on the New York Stock Exchange. - Bitget
VTAK Announces Definitive Merger Agreement to Acquire 100% of Fly Flyte Inc. - The Manila Times
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
CRTD (Creatd Inc.) Sells Remaining 80% of Fly Flyte to NYSE-Listed VTAK (Catheter Precision Inc.), Securing Significant Cash and Equity Position - Yahoo Finance
Catheter Precision Announces Strategic Financing and Aviation Acquisition - TipRanks
Catheter Precision to Acquire Flyte and Ponderosa From Creatd for $11.55 Million - TradingView
Catheter Precision, Inc. announced that it expects to receive $5.559 million in funding - marketscreener.com
How Catheter Precision Inc. (4RM0) stock compares with top peersSell Signal & High Accuracy Swing Entry Alerts - Naître et grandir
Catheter Precision’s LockeT suture retention device features at ISLAA 2026 - Yahoo Finance
Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026 - marketscreener.com
Heart procedure device promising same-day discharge tested live in L.A. - Stock Titan
Catheter Precision's (VTAK) LockeT Device to be Showcased at Int - GuruFocus
VTAK SEC FilingsCatheter Precision 10-K, 10-Q, 8-K Forms - Stock Titan
VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc. - 富途牛牛
VTAK Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Stop Loss: Can Catheter Precision Inc stock double in the next yearWeekly Trend Report & Trade Opportunity Analysis - baoquankhu1.vn
Retail Trends: Is Catheter Precision Inc stock undervalued right nowJuly 2025 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
VTAKCatheter Precision Latest Stock News & Market Updates - Stock Titan
Catheter Precision, Inc. Common Stock (NY: VTAK - The Chronicle-Journal
Catheter Precision Divests Non-Core Assets As It Shifts Focus - Benzinga
Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth - marketscreener.com
Electrophysiology firm sells catheter line for 5% stake and decade of royalties - Stock Titan
Catheter Precision acquires 20% stake in Creatd’s aviation subsidiary By Investing.com - Investing.com Australia
Royalty swapped for Series J preferred at Catheter Precision (VTAK) - Stock Titan
VTAK Acquires 20% Stake in Creatd’s Aviation Subsidiary Fly Flyte - citybuzz -
Catheter Precision acquires 20% stake in Creatd’s aviation subsidiary - Investing.com
Catheter Buys Stake in Fly Flyte - Baystreet.ca
VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc. - Benzinga
AI regional air service Fly Flyte gains NYSE investor VTAK - Stock Titan
VTAK Acquires 19.98% Strategic Stake in AI-Enabled Aviation Company Fly Flyte, Inc. - The Globe and Mail
What consensus target says about Catheter Precision Inc. stock2025 Analyst Calls & Long-Term Growth Stock Strategies - mfd.ru
Can Catheter Precision Inc. (4RM0) stock sustain margin levels2025 Performance Recap & Stepwise Trade Signal Implementation - mfd.ru
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Catheter Precision Secures Strategic Financing and Converts Royalties - TipRanks
Catheter Precision, Inc. secures up to $36.5 million in strategic institutional financing to accelerate growth - marketscreener.com
Breakout Watch: Is Catheter Precision Inc forming higher highs and higher lows2025 Major Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn
Catheter Precision Inc. Stock (VTAK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
1.47%
Cap:
|
Volume (24h):